Nevro Turns To Clinical Evidence To Attract Doctors, Patients And Reimbursement For Pain Therapy

The FDA recently approved Nevro’s Senza high-frequency spinal cord stimulation systems to treat pain caused by diabetic neuropathy. Now it plans to expand its proprietary HFX high-frequency treatment to more indications.